Ondansetron
Brand name: Ondansetron Odt
Rank #407 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$21.5M
Total Cost
1,261,950
Total Claims
$21.5M
Total Cost
50,152
Prescribers
$17
Cost per Claim
699,756
Beneficiaries
1,288,700
30-Day Fills
$429
Avg Cost/Provider
25
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$21.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $21.5M total
🔎 Data Overview
At $17.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Ondansetron
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Natalie Brixey | Family Practice | Tishomingo, OK | 24 | $23K |
| 2 | Michael Gibson | Interventional Pain Management | Hoover, AL | 54 | $22K |
| 3 | Christina Quale | Family Practice | Stoughton, WI | 13 | $20K |
| 4 | Ramon Santos Olivera | Family Practice | Anderson, IN | 93 | $14K |
| 5 | Matthew Olnes | Hematology-Oncology | Anchorage, AK | 33 | $14K |
| 6 | Jason Ham | Family Practice | Fort Payne, AL | 296 | $13K |
| 7 | Matthew Daab | Family Practice | Tuba City, AZ | 20 | $12K |
| 8 | Leah Raettig | Nurse Practitioner | New Bern, NC | 337 | $12K |
| 9 | Cheryl Kline | Nurse Practitioner | Mesa, AZ | 30 | $12K |
| 10 | Ashley Scott | Family Practice | Coweta, OK | 72 | $12K |
| 11 | Courtney Bowman | Nurse Practitioner | Wichita, KS | 47 | $11K |
| 12 | Kelly Garcia | Family Practice | Clyde, NC | 50 | $11K |
| 13 | Helena Kane | Internal Medicine | Denver, CO | 37 | $11K |
| 14 | Frank Smith | Physician Assistant | Poteau, OK | 13 | $11K |
| 15 | Debra Degering | Nurse Practitioner | Purcell, OK | 32 | $11K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
| 407 | Ondansetron (Ondansetron Odt) | $21.5M | 1,261,950 |
| 408 | Asciminib Hydrochloride (Scemblix) | $21.4M | 830 |
| 409 | Cephalexin (Cephalexin) | $21.4M | 2,407,718 |
| 410 | Teprotumumab-Trbw (Tepezza) | $21.4M | 389 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology